Search

Your search keyword '"Ready A"' showing total 414 results

Search Constraints

Start Over You searched for: Author "Ready A" Remove constraint Author: "Ready A" Database ScienceDirect Remove constraint Database: ScienceDirect
414 results on '"Ready A"'

Search Results

Catalog

Books, media, physical & digital resources

4. Identification of potent and reversible piperidine carboxamides that are species-selective orally active proteasome inhibitors to treat malaria

5. Lunar Flashlight science ground and flight measurements and operations using a multi-band laser reflectometer

8. Inducible mismatch repair streamlines forward genetic approaches to target identification of cytotoxic small molecules

10. International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy

14. Long-term survival with first-line nivolumab plus ipilimumab in patients with advanced non-small-cell lung cancer: a pooled analysis

16. BMS-986012, an Anti–Fucosyl-GM1 Monoclonal Antibody as Monotherapy or in Combination With Nivolumab in Relapsed/Refractory SCLC: Results From a First-in-Human Phase 1/2 Study

17. Daily use of lateral flow devices by contacts of confirmed COVID-19 cases to enable exemption from isolation compared with standard self-isolation to reduce onward transmission of SARS-CoV-2 in England: a randomised, controlled, non-inferiority trial

20. Frequency of transmission, asymptomatic shedding, and airborne spread of Streptococcus pyogenes in schoolchildren exposed to scarlet fever: a prospective, longitudinal, multicohort, molecular epidemiological, contact-tracing study in England, UK

27. Surface processing and discharge-conditioning of high voltage electrodes for the Ra EDM experiment

29. A Phase 1–2 Study of Rovalpituzumab Tesirine in Combination With Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Extensive-Stage SCLC

36. New Approaches to SCLC Therapy: From the Laboratory to the Clinic

39. Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort